November 3, 2025
CCR5 blockade: A therapeutic approach to uncouple CART-BCMA expansion from CART-mediated immune toxicities.
chemokine receptor type-5: a key regulator of immunity, disease pathogenesis, and emerging therapeutic target.
Inflammopharmacology, 08 Aug 2025 , 33(
CCR5 Gene Editing for HIV Cure Strategies June 2025
https://www.frontiersin.org/journals/immunolo...590690/pdf